Buy or sell Inari stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Inari Stock

Inari is a biotechnology company that aims to transform agriculture and its impact on society and the environment.

Founded

2016

Notable Investors

G Squared

Headquarters

Cambridge MA, US

Total Funding

$506M

About Inari Stock

Inari is a biotechnology company that aims to transform agriculture and its impact on society and the environment. It embraces diversity in every aspect of its business to drive innovation and help build a new food system. The company's technology matches the complexity of nature using predictive design and multiplex gene editing to unlock the full potential of the seed. Inari's SEEDesign platform is their point of distinction, using unsurpassed technology to enhance any crop for any geography to develop step-change products with a clear go-to-market approach. It was founded in 2016 and is based in Cambridge, MA.

Investors

Funding History

August 2018$40.0M
August 2019$89.0M
April 2020$45.0M
May 2021$208M
October 2022$124M

Management

CEO and Director

Ponsi Trivisvavet

Chief Scientific Officer

Catherine Feuillet

General Counsel

Pierre-Etienne Boin

Sr. VP, People

Nora Dutta

SVP, Innovation Catalyst

Michael Kock

Board Member

Solange Bullukian

Board Member

Ignacio Martinez

Scientific Strategy Board Member

Jennifer Doudna

Member of the Board of Directors

Robert Berendes

Director

Howard W. Buffett

Executive Chairman

Michael Mack

Scientific Strategy Board Member

George Church

Board Member

Moon-Ghee Ryu

Director

Rob Rosiello

Chief Financial Officer

Stuart Brown

Co-Founder & Director

Ignacio Martinez

Board Member

Sophie Vandebroek

Director

Bob Bechek

Board Member

Ponsi Trivisvavet

Join 290K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo